BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/4/2024 10:57:42 AM | Browse: 127 | Download: 169
Publication Name World Journal of Diabetes
Manuscript ID 89451
Country China
Received
2023-11-22 09:10
Peer-Review Started
2023-11-22 09:10
To Make the First Decision
Return for Revision
2023-12-08 01:21
Revised
2023-12-16 03:48
Second Decision
2024-01-09 01:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-01-16 05:29
Articles in Press
2024-01-16 05:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-01-29 17:28
Publish the Manuscript Online
2024-02-04 10:57
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Retrospective Study
Article Title Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis
Manuscript Source Unsolicited Manuscript
All Author List Fen Feng, Bin Zhou, Ci-La Zhou, Ping Huang, Gang Wang and Kuang Yao
ORCID
Author(s) ORCID Number
Fen Feng http://orcid.org/0009-0007-1376-8149
Bin Zhou http://orcid.org/0000-0001-6340-7105
Ci-La Zhou http://orcid.org/0009-0000-6419-4463
Ping Huang http://orcid.org/0009-0001-2173-3022
Gang Wang http://orcid.org/0009-0009-6493-5503
Kuang Yao http://orcid.org/0009-0007-4607-0249
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Plan Project of Shaoyang City No. 2022GX4139
Corresponding Author Bin Zhou, MM, Chief Physician, Department of Endocrinology, The Central Hospital of Shaoyang, No. 36 Qianyuan Lane, Hongqi Road, Daxiang District, Shaoyang 422099, Hunan Province, China. zhoubin790921@163.com
Key Words Type-2 diabetes mellitus; Hashimoto's thyroiditis; Vitamin D; Selenium agent; Hypoglycemic drugs; Curative effect
Core Tip Selenium yeast and active vitamin D can reduce thyroid-related antibodies in type-2 diabetes mellitus (T2DM) and Hashimoto's thyroiditis (HT) and improve thyroid function. Hypoglycemia drugs can lower blood sugar levels in patients and promote blood sugar stability. While most patients with T2DM and HT are currently treated with a single symptomatic drug, the effects are unsatisfactory. In this study, the combination of vitamin D and selenium yeast added to hypoglycemic agents to treat T2DM patients with HT showed a remarkable therapeutic effect.
Publish Date 2024-02-04 10:57
Citation Feng F, Zhou B, Zhou CL, Huang P, Wang G, Yao K. Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis. World J Diabetes 2024; 15(2): 209-219
URL https://www.wjgnet.com/1948-9358/full/v15/i2/209.htm
DOI https://dx.doi.org/10.4239/wjd.v15.i2.209
Full Article (PDF) WJD-15-209-with-cover.pdf
Full Article (Word) WJD-15-209.docx
Manuscript File 89451_Auto_Edited-YJP.docx
Answering Reviewers 89451-Answering reviewers.pdf
Audio Core Tip 89451-Audio core tip.MP3
Biostatistics Review Certificate 89451-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 89451-Conflict-of-interest statement.pdf
Copyright License Agreement 89451-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 89451-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 89451-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 89451-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 89451-Language certificate.pdf
Peer-review Report 89451-Peer-review(s).pdf
Scientific Misconduct Check 89451-Bing-Qu XL-2.jpg
Scientific Editor Work List 89451-Scientific editor work list.pdf